Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D02EHR
|
|||
| Drug Name |
PMID26293650-Compound-35
|
|||
| Drug Type |
Small molecular drug
|
|||
| Company |
DOMAINEX LIMITED PERRIOR, Trevor, Robert NEWTON, Gary, Karl STEWART, Mark, Richard AQIL, Rehan
|
|||
| Structure |
 |
Download2D MOL |
||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | NF-kappa-B-activating kinase (TBK1) | Target Info | Inhibitor | [1] |
| Target's Patent Info | NF-kappa-B-activating kinase (TBK1) | Target's Patent Info | [1] | |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | TBK1 inhibitors: a review of patent literature (2011 - 2014).Expert Opin Ther Pat. 2015;25(12):1385-96. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.